Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Bone and Mineral Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16234967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

  2005cited by this paper
• Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.

  2005cited by this paper
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005cited by this paper
• Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.

  2005cited by this paper
• A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.

  2005cited by this paper
• Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

  2005cited by this paper
• Circulating FGF-23 Is Regulated by 1α,25-Dihydroxyvitamin D3 and Phosphorus in Vivo*

  2005cited by this paper
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004cited by this paper
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• FGF-23 is elevated by chronic hyperphosphatemia.

  2004cited by this paper
• Bone as a source of FGF23: regulation by phosphate?

  2004cited by this paper
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

  2004cited by this paper
• Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.

  2004cited by this paper
• Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.

  2004cited by this paper
• What have we learnt about the regulation of phosphate metabolism?

  2004cited by this paper
• Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

  2004cited by this paper
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Osteomalacic and Hyperparathyroid Changes in Fibrous Dysplasia Of Bone: Core Biopsy Studies and Clinical Correlations

  2003cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003cited by this paper
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

  2003cited by this paper
• Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis

  2003cited by this paper
• FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

  2003cited by this paper
• Fibroblast growth factor 23 concentrations in humoral hypercalcemia of malignancy and hyperparathyroidism.

  2003cited by this paper
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002cited by this paper
• Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism

  2002cited by this paper
• The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

  2001cited by this paper
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001cited by this paper
• FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

  2001cited by this paper
• Hypophosphatemic rickets accompanying McCune–Albright syndrome: evidence that a humoral factor causes hypophosphatemia

  2001cited by this paper
• Disorders of phosphate metabolism.

  2000cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells.

  1998cited by this paper
• Control of proximal tubular apical Na/Pi cotransport.

  1996cited by this paper
• Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene.

  1995cited by this paper
• Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.

  1994cited by this paper
• The assessment of phosphate reabsorption.

  1969cited by this paper
• Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years.

  1947cited by this paper

• Lysophosphatidic Acid Synergizes With 1,25‐Dihydroxyvitamin D to Promote Fibroblast Growth Factor‐23 Synthesis via MAPK Signaling and Induction of the IL12A Gene

  2026cites this paper
• Correlation between serum 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D in response to analytical procedures; a systematic review and meta-analysis

  2024cites this paper
• Phosphate metabolism: its impact on disorders of mineral metabolism

  2024cites this paper
• 1,25-Dihydroxyvitamin D3 regulates furin-mediated FGF23 cleavage

  2023cites this paper
• Forestalling Hungry Bone Syndrome after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism

  2023cites this paper
• Chenodeoxycholic acid regulates fibroblast growth factor 23 gene expression via estrogen-related receptor γ in human hepatoma Huh7 cells.

  2023cites this paper
• Renal proximal tubule cells: power and finesse

  2023cites this paper
• Oral Acid Load Down-Regulates Fibroblast Growth Factor 23

  2022cites this paper
• Hypophosphatemia: A Practical Guide to Evaluation and Management.

  2022cites this paper
• Shedding Light on the Complex Regulation of FGF23

  2022cites this paper
• The effect of vitamin D supplementation on serum levels of fibroblast growth factor- 23: A systematic review and meta-analysis of randomized controlled trials.

  2021cites this paper
• PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1–34

  2021cites this paper
• Upstream Regulators of Fibroblast Growth Factor 23

  2021cites this paper
• Parathyroid Glands in Chronic Kidney Disease

  2020cites this paper
• Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels

  2020cites this paper
• C‐Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain‐of‐Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23

  2020cites this paper
• FGF/FGFR signaling in health and disease

  2020cites this paper
• 1,25(OH)2 vitamin D3 stimulates active phosphate transport but not paracellular phosphate absorption in mouse intestine

  2020cites this paper
• Regulation and Effects of FGF23 in Chronic Kidney Disease.

  2019cites this paper
• Successful management of tertiary hyperparathyroidism associated with hypophosphataemic rickets in an adult

  2019cites this paper
• FGF23 and Associated Disorders of Phosphate Wasting.

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• Hypophosphatemic Rickets.

  2019cites this paper
• Questioning the Safety of Calcidiol in Hemodialysis Patients

  2019cites this paper
• The dynamic relationships between the active and catabolic vitamin D metabolites, their ratios, and associations with PTH

  2019cites this paper
• FGF23 and the PTH response to paricalcitol in chronic kidney disease

  2019cites this paper
• Phosphate wasting disorders in adults

  2018cites this paper
• Heterotrimeric G proteins in the control of parathyroid hormone actions.

  2017cites this paper
• FGF23 Is Not Associated With Age-Related Changes in Phosphate, but Enhances Renal Calcium Reabsorption in Girls

  2017cites this paper
• Effect of Calcitriol on FGF23 Level in Healthy Adults and its Dependence on Phosphate Level.

  2017cites this paper
• Fibroblast Growth Factor 23-Mediated Bone Disease.

  2017cites this paper
• Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.

  2016cites this paper
• The FGF23/Klotho axis in the regulation of mineral and metabolic homeostasis

  2016cites this paper
• The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.

  2016cites this paper
• Fibroblast Growth Factor-23—A Potential Uremic Toxin

  2016cites this paper
• Ablation of the Stimulatory G Protein α-Subunit in Renal Proximal Tubules Leads to Parathyroid Hormone-Resistance With Increased Renal Cyp24a1 mRNA Abundance and Reduced Serum 1,25-Dihydroxyvitamin D.

  2016cites this paper
• 1,25‐Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?

  2016cites this paper
• Tumor-Induced Rickets in a Child With a Central Giant Cell Granuloma: A Case Report

  2015cites this paper
• The PTH-Vitamin D-FGF23 axis

  2015cites this paper
• Fibroblast Growth Factor 23

  2015cites this paper
• FGF23 is associated with disease severity and prognosis in chronic heart failure

  2014cites this paper
• Phosphate metabolism and vitamin D.

  2014cites this paper
• Generation of mice encoding a conditional null allele of Gcm2

  2014cites this paper
• The human response to acute enteral and parenteral phosphate loads.

  2014cites this paper
• Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice.

  2014cites this paper
• Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation

  2013cites this paper
• A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.

  2013cites this paper
• Ultraviolet B activated 1,25(OH)(2)D affects the level of fibroblast growth factor-23 in human.

  2013cites this paper
• Hyperphosphataemia: Treatment Options

  2013cites this paper
• Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.

  2012cites this paper
• Fibroblast growth factor 23: state of the field and future directions.

  2012cites this paper
• Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescents.

  2012cites this paper
• FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

  2012cites this paper
• UPDATE ON FIBROBLAST GROWTH FACTOR 23 IN CHRONIC KIDNEY DISEASE

  2012cites this paper
• Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.

  2011cites this paper
• An unusual case of hyperphosphatemia in a vitamin D-deficient patient with tuberculosis

  2011cites this paper
• Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end-stage renal disease: A case control study

  2011cites this paper
• Tumor-induced osteomalacia.

  2011cites this paper
• Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

  2010influential citation
• Fibroblast growth factor 23 and its role in phosphate homeostasis.

  2010cites this paper
• Cinin hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review

  2010cites this paper
• Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term.

  2010cites this paper
• Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients.

  2009cites this paper
• Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia.

  2009cites this paper
• Effects of hPTH(1‐34) Infusion on Circulating Serum Phosphate, 1,25‐Dihydroxyvitamin D, and FGF23 Levels in Healthy Men

  2009influential citation
• FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.

  2009cites this paper
• Chronic kidney disease/bone and mineral metabolism: the imperfect storm.

  2009cites this paper
• Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.

  2008cites this paper
• Vitamin D receptor genotype in hypophosphatemic rickets as a predictor of growth and response to treatment.

  2008cites this paper
• Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention

  2008cites this paper
• Fibroblast growth factor-23 regula tes parathyroid hormone and 1 a-hydroxylase expression in cultured bovine parathyroid cells

  2007cites this paper
• Determination of the elimination half-life of fibroblast growth factor-23.

  2007cites this paper
• Hepatic surgery-related hypophosphatemia.

  2007cites this paper
• Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

  2007cites this paper
• Regulatory Mechanisms of Circulating Fibroblast Growth Factor 23 in Parathyroid Diseases

  2007cites this paper
• 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

  2007cites this paper
• PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Role of Fibroblast Growth Factor 23 in Phosphate Homeostasis and Pathogenesis of Disordered Mineral Metabolism in Chronic Kidney Disease

  2007cites this paper
• The adaptation and relationship of FGF‐23 to changes in mineral metabolism in Graves’ disease

  2007cites this paper
• Novel PHEX Mutation Associated with Hypophosphatemic Rickets

  2007cites this paper
• Cinacalcet in the Management of Tumor‐Induced Osteomalacia

  2007influential citation
• Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.

  2006cites this paper
• Regulation or Permission?

  2006cites this paper
• FGF23: its role in renal bone disease

  2006cites this paper